bazedoxifene has been researched along with cyclin d1 in 2 studies
| Studies (bazedoxifene) | Trials (bazedoxifene) | Recent Studies (post-2010) (bazedoxifene) | Studies (cyclin d1) | Trials (cyclin d1) | Recent Studies (post-2010) (cyclin d1) |
|---|---|---|---|---|---|
| 307 | 69 | 249 | 10,885 | 70 | 5,157 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curpan, R; Grigg, R; Jordan, VC; Kim, H; Lewis-Wambi, JS; Sarker, MA | 1 |
| Cano, A; Dudenko, D; García-Pérez, MÁ; Gómez, R; Tarín, JJ | 1 |
2 other study(ies) available for bazedoxifene and cyclin d1
| Article | Year |
|---|---|
The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor α and cyclin D1.
Topics: Binding Sites; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Cyclin D1; Down-Regulation; Estrogen Receptor alpha; Female; Gene Knockdown Techniques; Humans; Indoles; Luciferases, Renilla; Selective Estrogen Receptor Modulators | 2011 |
Bazedoxifene increases the proliferation of human arterial endothelial cells but does not affect the expression of cyclins A, B, and D1 and of p27
Topics: Cell Proliferation; Cells, Cultured; Cyclin A; Cyclin B; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Endothelial Cells; Endothelium, Vascular; Female; Gene Expression; Humans; Indoles; Infant, Newborn; Pregnancy; Umbilical Arteries | 2021 |